ESSA Pharma Inc. (EPIX)

Oct 9, 2025 - EPIX was delisted (reason: acquired by XenoTherapeutics)

0.1951

-0.0061 (-3.03%)

Inactive · Last trade price on Oct 8, 2025

ESSA Pharma Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Operating Income	-29.66	-34.42	-32.13	-36.96	-37.14	-23.52
Net Income	-25.27	-28.54	-26.58	-35.1	-36.81	-23.45
Earnings Per Share	-0.57	-0.64	-0.60	-0.80	-0.96	-1.04
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Investments	109.62	126.76	148.08	167.24	194.93	78.33
Total Debt	-	0.33	0.08	0.21	0.33	0.06
Net Cash (Debt)	109.62	126.43	148	167.03	194.6	78.27
Net Cash Growth	-15.90%	-14.57%	-11.39%	-14.17%	148.61%	57.77%
Net Cash Per Share	2.47	2.86	3.36	3.79	5.06	3.49

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Operating Cash Flow	-20.88	-22.72	-19.78	-28	-25.42	-16.98
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	-20.88	-22.72	-19.78	-28	-25.42	-16.98
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.